Stock Alert: Genetic Technologies Jumps 50%

(RTTNews) - Shares of Genetic Technologies Ltd. (GENE) shares surged over 50% on Wednesday morning. The molecular diagnostics company said it has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in Australia.

GENE is currently trading at $3.51, up $1.25 or 55.31%, on the Nasdaq.

Genetic Technologies is developing a Polygenic Risk Score test for COVID-19, which may enable an assessment of risk of an individual developing a serious disease should they contract the COVID-19 virus. The test is intended to predict 'disease severity' using a combination of genetic and clinical information.

Genetic Technology expects to make its data pack for the COVID-19 Severity Risk Test available to global labs.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More